Rapid-dissolving Tablets Market Report

Global and Region Rapid-dissolving Tablets Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：221
  • REPORT CODE：GMM953333
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rapid-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

    The report details the trend, potential and market size of Rapid-dissolving Tablets market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Rapid-dissolving Tabletsmarket, defines the market attractiveness level of Rapid-dissolving Tablets market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Rapid-dissolving Tablets industry, describes the types of Rapid-dissolving Tablets market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rapid-dissolving Tablets market and the development prospects and opportunities of Rapid-dissolving Tablets industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rapid-dissolving Tablets market in Chapter 13.

    By Player:

    • GSK

    • Johnson and Johnson

    • Otsuka

    • Conquer

    • Bristol-Myers Squibb

    • Merck

    • AstraZeneca

    • Teva

    • Mylan

    • Pfizer

    • Eli Lilly and Company

    By Type:

    • Anti-Psychotics Drug

    • Anti-Epileptics Drug

    • Other

    By End-User:

    • CNS Diseases

    • Gastrointestinal Diseases

    • CVS Diseases

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Rapid-dissolving Tablets Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Rapid-dissolving Tablets Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Rapid-dissolving Tablets Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Rapid-dissolving Tablets Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Rapid-dissolving Tablets Market Analysis and Outlook to 2022

    • 7.1 Global Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.2 United States Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.3 Europe Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.4 China Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.5 Japan Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.6 India Rapid-dissolving Tablets Consumption (2017-2022)

    • 7.7 South Korea Rapid-dissolving Tablets Consumption (2017-2022)

    8 Region and Country-wise Rapid-dissolving Tablets Market Analysis and Outlook to 2028

    • 8.1 Global Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.2 United States Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.3 Europe Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.4 China Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.5 Japan Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.6 India Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    • 8.7 South Korea Rapid-dissolving Tablets Consumption Forecast (2022-2028)

    9 Global Rapid-dissolving Tablets Market Outlook by Types and Applications to 2022

    • 9.1 Global Rapid-dissolving Tablets Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anti-Psychotics Drug Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Anti-Epileptics Drug Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Rapid-dissolving Tablets Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global CNS Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global CVS Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Rapid-dissolving Tablets Market Outlook by Types and Applications to 2028

    • 10.1 Global Rapid-dissolving Tablets Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Anti-Psychotics Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Anti-Epileptics Drug Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Rapid-dissolving Tablets Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global CVS Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Rapid-dissolving Tablets Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Rapid-dissolving Tablets Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Rapid-dissolving Tablets Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Rapid-dissolving Tablets Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Rapid-dissolving Tablets Market Competitive Analysis

    • 14.1 GSK

      • 14.1.1 GSK Company Details

      • 14.1.2 GSK Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GSK Rapid-dissolving Tablets Product and Service

    • 14.2 Johnson and Johnson

      • 14.2.1 Johnson and Johnson Company Details

      • 14.2.2 Johnson and Johnson Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson and Johnson Rapid-dissolving Tablets Product and Service

    • 14.3 Otsuka

      • 14.3.1 Otsuka Company Details

      • 14.3.2 Otsuka Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Otsuka Rapid-dissolving Tablets Product and Service

    • 14.4 Conquer

      • 14.4.1 Conquer Company Details

      • 14.4.2 Conquer Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Conquer Rapid-dissolving Tablets Product and Service

    • 14.5 Bristol-Myers Squibb

      • 14.5.1 Bristol-Myers Squibb Company Details

      • 14.5.2 Bristol-Myers Squibb Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bristol-Myers Squibb Rapid-dissolving Tablets Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Rapid-dissolving Tablets Product and Service

    • 14.7 AstraZeneca

      • 14.7.1 AstraZeneca Company Details

      • 14.7.2 AstraZeneca Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca Rapid-dissolving Tablets Product and Service

    • 14.8 Teva

      • 14.8.1 Teva Company Details

      • 14.8.2 Teva Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Teva Rapid-dissolving Tablets Product and Service

    • 14.9 Mylan

      • 14.9.1 Mylan Company Details

      • 14.9.2 Mylan Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Mylan Rapid-dissolving Tablets Product and Service

    • 14.10 Pfizer

      • 14.10.1 Pfizer Company Details

      • 14.10.2 Pfizer Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Pfizer Rapid-dissolving Tablets Product and Service

    • 14.11 Eli Lilly and Company

      • 14.11.1 Eli Lilly and Company Company Details

      • 14.11.2 Eli Lilly and Company Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Eli Lilly and Company Rapid-dissolving Tablets Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Rapid-dissolving Tablets

    • Figure Rapid-dissolving Tablets Picture

    • Table Global Rapid-dissolving Tablets Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rapid-dissolving Tablets Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Rapid-dissolving Tablets Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Rapid-dissolving Tablets Consumption by Country (2017-2022)

    • Figure United States Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Table Europe Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Figure China Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Figure Japan Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Figure India Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Figure South Korea Rapid-dissolving Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Rapid-dissolving Tablets Consumption Forecast by Country (2022-2028)

    • Figure United States Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Rapid-dissolving Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Psychotics Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Epileptics Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global CNS Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global CVS Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-Psychotics Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anti-Epileptics Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CVS Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Rapid-dissolving Tablets Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Rapid-dissolving Tablets Export by Region (Top 5 Countries) (2017-2028)

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Rapid-dissolving Tablets Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Rapid-dissolving Tablets Product and Service

    • Table Otsuka (Foundation Year, Company Profile and etc.)

    • Table Otsuka Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Rapid-dissolving Tablets Product and Service

    • Table Conquer (Foundation Year, Company Profile and etc.)

    • Table Conquer Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Conquer Rapid-dissolving Tablets Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Rapid-dissolving Tablets Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Rapid-dissolving Tablets Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Rapid-dissolving Tablets Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Rapid-dissolving Tablets Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Rapid-dissolving Tablets Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Rapid-dissolving Tablets Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Rapid-dissolving Tablets Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Rapid-dissolving Tablets Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US